其中4篇入选封面文章；在《New England Journal of Medicine》发表文章1篇。其研究成果累计影响因子达482.1分，单篇最高影响因子96.2分。2024年上半年 ...

其中4篇入选封面文章；在《New England Journal of Medicine》发表文章1篇。其研究成果累计影响因子达482.1分，单篇最高影响因子96.2分。2024年上半年，在全球放射科最活跃的医生科学家中排名第三。

其中4篇入选封面文章；在《New England Journal of Medicine》发表文章1篇。其研究成果累计影响因子达482.1分，单篇最高影响因子96.2分。2024年上半年 ...

排便不顺利是当代年轻人最大的痛点之一。 一条“祈求拉屎自由，没有便秘困扰”的小红书帖子下面获得了数条“接排便通畅 ...

State Medicaid agencies can now apply to participate in a new model that supports voluntary, outcomes-based agreements between Medicaid programs and manufacturers of gene therapies for sickle cell ...

For decades, poor treatment options and low-quality evidence plagued care for patients with rifampin-resistant tuberculosis. The advent of new drugs to treat tuberculosis and enhanced funding now ...

Allogeneic hematopoietic stem-cell transplantation is the only curative treatment for myelofibrosis. Driver mutations are the pathophysiological hallmark of the disease, but the role of mutation ...

The continuous emergence and reemergence of tickborne diseases have presented an increasing threat to human health. 1,2 We conducted an active surveillance of febrile patients with recent tick ...

2 The steering committee members and the sponsor vouch for the adherence of the trial to the protocol (available with the full text of this article at NEJM.org). All the authors vouch for the ...

Disclosure forms provided by the authors are available at NEJM.org. We thank the A-Team Foundation (London), the Owsley Brown II Family Foundation (Louisville, KY), and the Minderoo Foundation ...

Additional inclusion and exclusion criteria are provided in the Supplementary Appendix, available at NEJM.org. Participants were randomly assigned in a 1:1:1 ratio to receive a hydrophobic PICC ...